Tamara Isakova1, Timothy E Craven2, Julia J Scialla3, Thomas L Nickolas4, Adrian Schnall5, Joshua Barzilay6, Ann V Schwartz7. 1. Department of Medicine, Division of Nephrology, Institute of Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: tamara.isakova@northwestern.edu. 2. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 3. Department of Medicine, Division of Nephrology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. 4. Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, NY, USA. 5. University Suburban Health Center, South Euclid, OH, USA. 6. Division of Endocrinology, Kaiser Permanente of Georgia and Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, USA. 7. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Abstract
OBJECTIVE:Patients with type 2 diabetes (T2DM) are at increased risk of fracture. High prevalence of chronic kidney disease (CKD) in T2DM may contribute to bone fragility, but whether dynamic change in kidney function is associated with fracture risk is unclear. RESEARCH DESIGN AND METHODS: To evaluate the association of pre-randomization baseline estimated glomerular filtration (eGFR) and its change over time with subsequent fracture risk in the Bone substudy of Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, we conducted an observational study of 2262 women and 4737 men with T2DM and with at least 2 eGFR values. RESULTS: During a mean follow-up of 4.40±1.54 years, 235 women and 223 men sustained a new non-vertebral fracture. In multivariable adjusted sex-specific models, pre-randomization baseline eGFR was not a significant predictor of fracture risk in either men or women. However, a steeper decline in eGFR was associated with greater risk of fracture in women (hazard ratio [HR] per standard deviation [SD] decrement in eGFR slope, 1.30; 95% CI 1.17-1.44) but not men (HR per SD decrement in eGFR slope, 0.97; 95%CI 0.82-1.13). Accounting for competing risk of death modestly attenuated the association in women (HR per SD decrement in eGFR slope, 1.19; 95% CI 1.04-1.37), with the relationship in men remaining non-significant (HR per SD decrement in eGFR slope, 0.96; 95% CI 0.77-1.18). CONCLUSIONS: Declining kidney function predicts fracture risk in women but not in men with T2DM. Future studies should investigate the mechanisms for these associations.
RCT Entities:
OBJECTIVE:Patients with type 2 diabetes (T2DM) are at increased risk of fracture. High prevalence of chronic kidney disease (CKD) in T2DM may contribute to bone fragility, but whether dynamic change in kidney function is associated with fracture risk is unclear. RESEARCH DESIGN AND METHODS: To evaluate the association of pre-randomization baseline estimated glomerular filtration (eGFR) and its change over time with subsequent fracture risk in the Bone substudy of Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, we conducted an observational study of 2262 women and 4737 men with T2DM and with at least 2 eGFR values. RESULTS: During a mean follow-up of 4.40±1.54 years, 235 women and 223 men sustained a new non-vertebral fracture. In multivariable adjusted sex-specific models, pre-randomization baseline eGFR was not a significant predictor of fracture risk in either men or women. However, a steeper decline in eGFR was associated with greater risk of fracture in women (hazard ratio [HR] per standard deviation [SD] decrement in eGFR slope, 1.30; 95% CI 1.17-1.44) but not men (HR per SD decrement in eGFR slope, 0.97; 95%CI 0.82-1.13). Accounting for competing risk of death modestly attenuated the association in women (HR per SD decrement in eGFR slope, 1.19; 95% CI 1.04-1.37), with the relationship in men remaining non-significant (HR per SD decrement in eGFR slope, 0.96; 95% CI 0.77-1.18). CONCLUSIONS: Declining kidney function predicts fracture risk in women but not in men with T2DM. Future studies should investigate the mechanisms for these associations.
Authors: A V Schwartz; D E Sellmeyer; K E Ensrud; J A Cauley; H K Tabor; P J Schreiner; S A Jamal; D M Black; S R Cummings Journal: J Clin Endocrinol Metab Date: 2001-01 Impact factor: 5.958
Authors: Michelle C Odden; Glenn M Chertow; Linda F Fried; Anne B Newman; Stephanie Connelly; Sara Angleman; Tamara B Harris; Eleanor M Simonsick; Michael G Shlipak Journal: Am J Epidemiol Date: 2006-10-11 Impact factor: 4.897
Authors: Ann V Schwartz; Deborah E Sellmeyer; Eric Vittinghoff; Lisa Palermo; Beata Lecka-Czernik; Kenneth R Feingold; Elsa S Strotmeyer; Helaine E Resnick; Laura Carbone; Brock A Beamer; Seok Won Park; Nancy E Lane; Tamara B Harris; Steven R Cummings Journal: J Clin Endocrinol Metab Date: 2006-04-11 Impact factor: 5.958
Authors: I I de Liefde; M van der Klift; C E D H de Laet; P L A van Daele; A Hofman; H A P Pols Journal: Osteoporos Int Date: 2005-06-07 Impact factor: 4.507
Authors: Linda F Fried; Mary Louise Biggs; Michael G Shlipak; Stephen Seliger; Bryan Kestenbaum; Catherine Stehman-Breen; Mark Sarnak; David Siscovick; Tamara Harris; Jane Cauley; Anne B Newman; John Robbins Journal: J Am Soc Nephrol Date: 2006-12-13 Impact factor: 10.121
Authors: Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli Journal: Cochrane Database Syst Rev Date: 2017-06-08
Authors: N C Wright; E R Hooker; C M Nielson; K E Ensrud; S L Harrison; E S Orwoll; E Barrett-Connor Journal: Osteoporos Int Date: 2018-01-17 Impact factor: 4.507